Published in:

01-12-2015 | Erratum

Erratum to: Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease

Authors: Saima Hassan, MD, PhD, FRCSC, Teresa M. Petrella, MD, MSc, FRCPC, Tong Zhang, MSc, Suzanne Kamel-Reid, BA, MA, PhD, FACMG, Francesco Nordio, PhD, Andrea Baccarelli, MD, PhD, Shachar Sade, MD, MSc, FRCPC, Karen Naert, MD, FRCPC, Ayman Al Habeeb, MBBS, FRCPC, Danny Ghazarian, MB ChB, PhD, FRCPC, FCAP, Frances C. Wright, MD, MEd, FRCSC

Published in: Annals of Surgical Oncology | Special Issue 3/2015